Asthma – Pipeline Review, H2 2017

Global Markets Direct’s, ‘Asthma – Pipeline Review, H2 2017’, provides an overview of the Asthma pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Asthma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Asthma and features dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the global therapeutic landscape of Asthma

The report reviews pipeline therapeutics for Asthma by companies and universities/research institutes based on information derived from company and industry-specific sources

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report reviews key players involved Asthma therapeutics and enlists all their major and minor projects

The report assesses Asthma therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report summarizes all the dormant and discontinued pipeline projects

The report reviews latest news related to pipeline therapeutics for Asthma

Reasons to buy

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Asthma

Identify potential new clients or partners in the target demographic

Develop strategic initiatives by understanding the focus areas of leading companies

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Asthma pipeline depth and focus of Indication therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Companies mentioned

4D Pharma PLC

AB Science SA

AbbVie Inc

Abeome Corp

Accolade Pharmaceuticals LLC

Adamis Pharmaceuticals Corp

ALK-Abello A/S

Allergan Plc

Allergopharma GmbH & Co KG

Almirall SA

Amgen Inc

AnaptysBio Inc

AnGes MG Inc

Antisense Therapeutics Ltd

Apollo Endosurgery Inc

ARA Healthcare Pvt Ltd

ASIT Biotech SA

Aslan Pharmaceuticals Pte Ltd

Astellas Pharma Inc

AstraZeneca Plc

Aurigene Discovery Technologies Ltd

Axikin Pharmaceuticals Inc

Biotec Pharmacon ASA

Boehringer Ingelheim GmbH

Celldex Therapeutics Inc

Cellular Biomedicine Group Inc

Celon Pharma SA

Chiesi Farmaceutici SpA

Circassia Pharmaceuticals Plc

Cognosci Inc

Crossject SA

Cumberland Pharmaceuticals Inc

Cynata Therapeutics Ltd

Cytokinetics Inc

Daiichi Sankyo Co Ltd

Denceptor Therapeutics Ltd

Energenesis Biomedical Co Ltd

Enterprise Therapeutics Ltd

F. Hoffmann-La Roche Ltd

Foresee Pharmaceuticals LLC

Fountain Biopharma Inc

Genentech Inc

GlaxoSmithKline Plc

Glenmark Pharmaceuticals Ltd

Griffin Discoveries BV

Han Wha Pharma Co Ltd

Hydra Biosciences Inc

iCeutica Inc

iCo Therapeutics Inc.

Idorsia Ltd

Immupharma Plc

InKemia IUCT Group SA

Inspyr Therapeutics Inc

Intech Biopharm Ltd

Invion Ltd

Jiangsu Hansoh Pharmaceutical Group Co Ltd

Johnson & Johnson

Kissei Pharmaceutical Co Ltd

KPI Therapeutics Inc

Kyowa Hakko Kirin Co Ltd

Laboratorios LETI SL

Lead Discovery Center GmbH

MedImmune LLC

Merck & Co Inc

Mitsubishi Tanabe Pharma Corp

Mundipharma International Ltd

Mycenax Biotech Inc

NAL Pharmaceuticals Ltd

NeoPharm Co Ltd

Novartis AG

Omeros Corp

Ono Pharmaceutical Co Ltd

OPKO Health Inc

Orbis Biosciences Inc

Orchid Pharma Ltd

Orion Corporation

Oxagen Ltd

Paradigm Biopharmaceuticals Ltd

Pfizer Inc

Pharmaxis Ltd

Pieris Pharmaceuticals Inc

Polyphor Ltd

Progenra Inc

Promedior Inc

Prommune Inc

Pulmagen Therapeutics LLP

Pulmatrix Inc

Pulmokine Inc

Pulmotect Inc

Qu Biologics Inc

Qurient Co Ltd

Re-Pharm Ltd

Regeneron Pharmaceuticals Inc

Reliance Life Sciences Pvt Ltd

Respiratorius AB

ReveraGen BioPharma Inc

Rhizen Pharmaceuticals SA

Saje Pharma LLC

Shire Plc

SolAeroMed Inc

Sterna biologicals Gmbh & Co KG

Sumitomo Dainippon Pharma Co Ltd

Sun Pharma Advanced Research Company Ltd

Sun Pharmaceutical Industries Ltd

Sunovion Pharmaceuticals Inc

Swecure AB

Synermore Biologics Co Ltd

Syntrix Biosystems Inc

TaiwanJ Pharmaceuticals Co Ltd

Teva Pharmaceutical Industries Ltd

Therabron Therapeutics Inc

Theravance Biopharma Inc

Tolerys SA

United BioPharma Inc

Vectura Group Plc

Verona Pharma Plc

WhanIn Pharmaceutical Co Ltd

Xencor Inc

Yungjin Pharm Co Ltd

Zai Lab Ltd

Table of Contents

Table of Contents

Table of Contents 2

Introduction 7

Asthma - Overview 8

Asthma - Therapeutics Development 9

Asthma - Therapeutics Assessment 39

Asthma - Companies Involved in Therapeutics Development 57

Asthma - Drug Profiles 112

Asthma - Dormant Projects 559

Asthma - Discontinued Products 581

Asthma - Product Development Milestones 587

Appendix 599

List of Tables

List of Tables

Number of Products under Development for Asthma, H2 2017

Number of Products under Development by Companies, H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..1), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..2), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..3), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..4), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..5), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..6), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..7), H2 2017

Number of Products under Development by Companies, H2 2017 (Contd..8), H2 2017

Number of Products under Development by Universities/Institutes, H2 2017

Number of Products under Development by Universities/Institutes, H2 2017 (Contd..1), H2 2017

Products under Development by Companies, H2 2017

Products under Development by Companies, H2 2017 (Contd..1), H2 2017

Products under Development by Companies, H2 2017 (Contd..2), H2 2017

Products under Development by Companies, H2 2017 (Contd..3), H2 2017

Products under Development by Companies, H2 2017 (Contd..4), H2 2017

Products under Development by Companies, H2 2017 (Contd..5), H2 2017

Products under Development by Companies, H2 2017 (Contd..6), H2 2017

Products under Development by Companies, H2 2017 (Contd..7), H2 2017

Products under Development by Companies, H2 2017 (Contd..8), H2 2017

Products under Development by Companies, H2 2017 (Contd..9), H2 2017

Products under Development by Companies, H2 2017 (Contd..10), H2 2017

Products under Development by Companies, H2 2017 (Contd..11), H2 2017

Products under Development by Companies, H2 2017 (Contd..12), H2 2017

Products under Development by Companies, H2 2017 (Contd..13), H2 2017

Products under Development by Universities/Institutes, H2 2017

Products under Development by Universities/Institutes, H2 2017 (Contd..1), H2 2017

Number of Products by Stage and Target, H2 2017

Number of Products by Stage and Target, H2 2017 (Contd..1), H2 2017

Number of Products by Stage and Target, H2 2017 (Contd..2), H2 2017

Number of Products by Stage and Target, H2 2017 (Contd..3), H2 2017

Number of Products by Stage and Target, H2 2017 (Contd..4), H2 2017

Number of Products by Stage and Target, H2 2017 (Contd..5), H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..1), H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..2), H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..3), H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..4), H2 2017

Number of Products by Stage and Mechanism of Action, H2 2017 (Contd..5), H2 2017

Number of Products by Stage and Route of Administration, H2 2017

Number of Products by Stage and Molecule Type, H2 2017

Asthma – Pipeline by 4D Pharma PLC, H2 2017

Asthma – Pipeline by AB Science SA, H2 2017

Asthma – Pipeline by AbbVie Inc, H2 2017

Asthma – Pipeline by Abeome Corp, H2 2017

Asthma – Pipeline by Accolade Pharmaceuticals LLC, H2 2017

Asthma – Pipeline by Adamis Pharmaceuticals Corp, H2 2017

Asthma – Pipeline by ALK-Abello A/S, H2 2017

Asthma – Pipeline by Allergan Plc, H2 2017

Asthma – Pipeline by Allergopharma GmbH & Co KG, H2 2017

Asthma – Pipeline by Almirall SA, H2 2017

Asthma – Pipeline by Amgen Inc, H2 2017

Asthma – Pipeline by AnaptysBio Inc, H2 2017

Asthma – Pipeline by AnGes MG Inc, H2 2017

Asthma – Pipeline by Antisense Therapeutics Ltd, H2 2017

Asthma – Pipeline by Apollo Endosurgery Inc, H2 2017

Asthma – Pipeline by ARA Healthcare Pvt Ltd, H2 2017

Asthma – Pipeline by ASIT Biotech SA, H2 2017

Asthma – Pipeline by Aslan Pharmaceuticals Pte Ltd, H2 2017

Asthma – Pipeline by Astellas Pharma Inc, H2 2017

Asthma – Pipeline by AstraZeneca Plc, H2 2017

Asthma – Pipeline by Aurigene Discovery Technologies Ltd, H2 2017

Asthma – Pipeline by Axikin Pharmaceuticals Inc, H2 2017

Asthma – Pipeline by Biotec Pharmacon ASA, H2 2017

Asthma – Pipeline by Boehringer Ingelheim GmbH, H2 2017

Asthma – Pipeline by Celldex Therapeutics Inc, H2 2017

Asthma – Pipeline by Cellular Biomedicine Group Inc, H2 2017

Asthma – Pipeline by Celon Pharma SA, H2 2017

Asthma – Pipeline by Chiesi Farmaceutici SpA, H2 2017

Asthma – Pipeline by Circassia Pharmaceuticals Plc, H2 2017

Asthma – Pipeline by Cognosci Inc, H2 2017

Asthma – Pipeline by Crossject SA, H2 2017

Asthma – Pipeline by Cumberland Pharmaceuticals Inc, H2 2017

Asthma – Pipeline by Cynata Therapeutics Ltd, H2 2017

Asthma – Pipeline by Cytokinetics Inc, H2 2017

Asthma – Pipeline by Daiichi Sankyo Co Ltd, H2 2017

Asthma – Pipeline by Denceptor Therapeutics Ltd, H2 2017

Asthma – Pipeline by Energenesis Biomedical Co Ltd, H2 2017

Asthma – Pipeline by Enterprise Therapeutics Ltd, H2 2017

Asthma – Pipeline by F. Hoffmann-La Roche Ltd, H2 2017

Asthma – Pipeline by Foresee Pharmaceuticals LLC, H2 2017

Asthma – Pipeline by Fountain Biopharma Inc, H2 2017

Asthma – Pipeline by Genentech Inc, H2 2017

Asthma – Pipeline by GlaxoSmithKline Plc, H2 2017

Asthma – Pipeline by Glenmark Pharmaceuticals Ltd, H2 2017

Asthma – Pipeline by Griffin Discoveries BV, H2 2017

Asthma – Pipeline by Han Wha Pharma Co Ltd, H2 2017

Asthma – Pipeline by Hydra Biosciences Inc, H2 2017

Asthma – Pipeline by iCeutica Inc, H2 2017

Asthma – Pipeline by iCo Therapeutics Inc., H2 2017

Asthma – Pipeline by Idorsia Ltd, H2 2017

Asthma – Pipeline by Immupharma Plc, H2 2017

Asthma – Pipeline by InKemia IUCT Group SA, H2 2017

Asthma – Pipeline by Inspyr Therapeutics Inc, H2 2017

Asthma – Pipeline by Intech Biopharm Ltd, H2 2017

Asthma – Pipeline by Invion Ltd, H2 2017

Asthma – Pipeline by Jiangsu Hansoh Pharmaceutical Group Co Ltd, H2 2017

Asthma – Pipeline by Johnson & Johnson, H2 2017

Asthma – Pipeline by Kissei Pharmaceutical Co Ltd, H2 2017

Asthma – Pipeline by KPI Therapeutics Inc, H2 2017

Asthma – Pipeline by Kyowa Hakko Kirin Co Ltd, H2 2017

Asthma – Pipeline by Laboratorios LETI SL, H2 2017

Asthma – Pipeline by Lead Discovery Center GmbH, H2 2017

Asthma – Pipeline by MedImmune LLC, H2 2017

Asthma – Pipeline by Merck & Co Inc, H2 2017

Asthma – Pipeline by Mitsubishi Tanabe Pharma Corp, H2 2017

Asthma – Pipeline by Mundipharma International Ltd, H2 2017

Asthma – Pipeline by Mycenax Biotech Inc, H2 2017

Asthma – Pipeline by NAL Pharmaceuticals Ltd, H2 2017

Asthma – Pipeline by NeoPharm Co Ltd, H2 2017

Asthma – Pipeline by Novartis AG, H2 2017

Asthma – Pipeline by Omeros Corp, H2 2017

Asthma – Pipeline by Ono Pharmaceutical Co Ltd, H2 2017

Asthma – Pipeline by OPKO Health Inc, H2 2017

Asthma – Pipeline by Orbis Biosciences Inc, H2 2017

Asthma – Pipeline by Orchid Pharma Ltd, H2 2017

Asthma – Pipeline by Orion Corporation, H2 2017

Asthma – Pipeline by Oxagen Ltd, H2 2017

Asthma – Pipeline by Paradigm Biopharmaceuticals Ltd, H2 2017

Asthma – Pipeline by Pfizer Inc, H2 2017

Asthma – Pipeline by Pharmaxis Ltd, H2 2017

Asthma – Pipeline by Pieris Pharmaceuticals Inc, H2 2017

Asthma – Pipeline by Polyphor Ltd, H2 2017

Asthma – Pipeline by Progenra Inc, H2 2017

Asthma – Pipeline by Promedior Inc, H2 2017

Asthma – Pipeline by Prommune Inc, H2 2017

Asthma – Pipeline by Pulmagen Therapeutics LLP, H2 2017

Asthma – Pipeline by Pulmatrix Inc, H2 2017

Asthma – Pipeline by Pulmokine Inc, H2 2017

Asthma – Pipeline by Pulmotect Inc, H2 2017

Asthma – Pipeline by Qu Biologics Inc, H2 2017

Asthma – Pipeline by Qurient Co Ltd, H2 2017

Asthma – Pipeline by Re-Pharm Ltd, H2 2017

Asthma – Pipeline by Regeneron Pharmaceuticals Inc, H2 2017

Asthma – Pipeline by Reliance Life Sciences Pvt Ltd, H2 2017

Asthma – Pipeline by Respiratorius AB, H2 2017

Asthma – Pipeline by ReveraGen BioPharma Inc, H2 2017

Asthma – Pipeline by Rhizen Pharmaceuticals SA, H2 2017

Asthma – Pipeline by Saje Pharma LLC, H2 2017

Asthma – Pipeline by Shire Plc, H2 2017

Asthma – Pipeline by SolAeroMed Inc, H2 2017

Asthma – Pipeline by sterna biologicals Gmbh & Co KG, H2 2017

Asthma – Pipeline by Sumitomo Dainippon Pharma Co Ltd, H2 2017

Asthma – Pipeline by Sun Pharma Advanced Research Company Ltd, H2 2017

Asthma – Pipeline by Sun Pharmaceutical Industries Ltd, H2 2017

Asthma – Pipeline by Sunovion Pharmaceuticals Inc, H2 2017

Asthma – Pipeline by Swecure AB, H2 2017

Asthma – Pipeline by Synermore Biologics Co Ltd, H2 2017

Asthma – Pipeline by Syntrix Biosystems Inc, H2 2017

Asthma – Pipeline by TaiwanJ Pharmaceuticals Co Ltd, H2 2017

Asthma – Pipeline by Teva Pharmaceutical Industries Ltd, H2 2017

Asthma – Pipeline by Therabron Therapeutics Inc, H2 2017

Asthma – Pipeline by Theravance Biopharma Inc, H2 2017

Asthma – Pipeline by Tolerys SA, H2 2017

Asthma – Pipeline by United BioPharma Inc, H2 2017

Asthma – Pipeline by Vectura Group Plc, H2 2017

Asthma – Pipeline by Verona Pharma Plc, H2 2017

Asthma – Pipeline by WhanIn Pharmaceutical Co Ltd, H2 2017

Asthma – Pipeline by Xencor Inc, H2 2017

Asthma – Pipeline by Yungjin Pharm Co Ltd, H2 2017

Asthma – Pipeline by Zai Lab Ltd, H2 2017

Asthma – Dormant Projects, H2 2017

Asthma – Dormant Projects, H2 2017 (Contd..1), H2 2017

Asthma – Dormant Projects, H2 2017 (Contd..2), H2 2017

Asthma – Dormant Projects, H2 2017 (Contd..3), H2 2017

Asthma – Dormant Projects, H2 2017 (Contd..4), H2 2017

Asthma – Dormant Projects, H2 2017 (Contd..5), H2 2017

Asthma – Dormant Projects, H2 2017 (Contd..6), H2 2017

Asthma – Dormant Projects, H2 2017 (Contd..7), H2 2017

Asthma – Dormant Projects, H2 2017 (Contd..8), H2 2017

Asthma – Dormant Projects, H2 2017 (Contd..9), H2 2017

Asthma – Dormant Projects, H2 2017 (Contd..10), H2 2017

Asthma – Dormant Projects, H2 2017 (Contd..11), H2 2017

Asthma – Dormant Projects, H2 2017 (Contd..12), H2 2017

Asthma – Dormant Projects, H2 2017 (Contd..13), H2 2017

Asthma – Dormant Projects, H2 2017 (Contd..14), H2 2017

Asthma – Dormant Projects, H2 2017 (Contd..15), H2 2017

Asthma – Dormant Projects, H2 2017 (Contd..16), H2 2017

Asthma – Dormant Projects, H2 2017 (Contd..17), H2 2017

Asthma – Dormant Projects, H2 2017 (Contd..18), H2 2017

Asthma – Dormant Projects, H2 2017 (Contd..19), H2 2017

Asthma – Dormant Projects, H2 2017 (Contd..20), H2 2017

Asthma – Discontinued Products, H2 2017

Asthma – Discontinued Products, H2 2017 (Contd..1), H2 2017

Asthma – Discontinued Products, H2 2017 (Contd..2), H2 2017

Asthma – Discontinued Products, H2 2017 (Contd..3), H2 2017

Asthma – Discontinued Products, H2 2017 (Contd..4), H2 2017

Asthma – Discontinued Products, H2 2017 (Contd..5), H2 2017

List of Figures

List of Figures

Number of Products under Development for Asthma, H2 2017

Number of Products under Development by Companies, H2 2017

Number of Products under Development by Universities/Institutes, H2 2017

Number of Products by Top 10 Targets, H2 2017

Number of Products by Stage and Top 10 Targets, H2 2017

Number of Products by Top 10 Mechanism of Actions, H2 2017

Number of Products by Stage and Top 10 Mechanism of Actions, H2 2017

Number of Products by Routes of Administration, H2 2017

Number of Products by Stage and Routes of Administration, H2 2017

Number of Products by Top 10 Molecule Types, H2 2017

Number of Products by Stage and Top 10 Molecule Types, H2 2017

    Pricing

Discounts available for multiple purchases.

reportstore@globalmarketsdirect.com
+44 20 7947 2745

Saved reports